3/20/2013

A financing round has pulled in $1.1 million for Lumora, a U.K.-based firm focused on molecular diagnostics. The company will use the proceeds to expand the commercialization of its Bioluminescent Assay in Real Time, or BART, system and other diagnostic products in Europe and the U.S.

Related Summaries